Global Hospital-acquired Urinary Tract Infection Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Hospital-acquired Urinary Tract Infection Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Assay kits and consumables
  • 1.4.3 Instruments
• 1.5 Market by Application
  • 1.5.1 Global Hospital-acquired Urinary Tract Infection Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and outpatient department
  • 1.5.3 Diagnostics clinical laboratories
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Perspective (2015-2026)
• 2.2 Global Hospital-acquired Urinary Tract Infection Testing Growth Trends by Regions
  • 2.2.1 Hospital-acquired Urinary Tract Infection Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Hospital-acquired Urinary Tract Infection Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Hospital-acquired Urinary Tract Infection Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Hospital-acquired Urinary Tract Infection Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Hospital-acquired Urinary Tract Infection Testing Players by Market Size
  • 3.1.1 Global Top Hospital-acquired Urinary Tract Infection Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Hospital-acquired Urinary Tract Infection Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Hospital-acquired Urinary Tract Infection Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio
  • 3.2.1 Global Hospital-acquired Urinary Tract Infection Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Hospital-acquired Urinary Tract Infection Testing Revenue in 2019
• 3.3 Hospital-acquired Urinary Tract Infection Testing Key Players Head office and Area Served
• 3.4 Key Players Hospital-acquired Urinary Tract Infection Testing Product Solution and Service
• 3.5 Date of Enter into Hospital-acquired Urinary Tract Infection Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Hospital-acquired Urinary Tract Infection Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)
• 5.2 Global Hospital-acquired Urinary Tract Infection Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 6.2 Hospital-acquired Urinary Tract Infection Testing Key Players in North America (2019-2020)
• 6.3 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 6.4 North America Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 7.2 Hospital-acquired Urinary Tract Infection Testing Key Players in Europe (2019-2020)
• 7.3 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 7.4 Europe Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 8.2 Hospital-acquired Urinary Tract Infection Testing Key Players in China (2019-2020)
• 8.3 China Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 8.4 China Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 9.2 Hospital-acquired Urinary Tract Infection Testing Key Players in Japan (2019-2020)
• 9.3 Japan Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 9.4 Japan Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 10.2 Hospital-acquired Urinary Tract Infection Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 11.2 Hospital-acquired Urinary Tract Infection Testing Key Players in India (2019-2020)
• 11.3 India Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 11.4 India Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Hospital-acquired Urinary Tract Infection Testing Market Size (2015-2020)
• 12.2 Hospital-acquired Urinary Tract Infection Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Hospital-acquired Urinary Tract Infection Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Hospital-acquired Urinary Tract Infection Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 bioMérieux
  • 13.1.1 bioMérieux Company Details
  • 13.1.2 bioMérieux Business Overview
  • 13.1.3 bioMérieux Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.1.4 bioMérieux Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020))
  • 13.1.5 bioMérieux Recent Development
• 13.2 Roche Diagnostics
  • 13.2.1 Roche Diagnostics Company Details
  • 13.2.2 Roche Diagnostics Business Overview
  • 13.2.3 Roche Diagnostics Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.2.4 Roche Diagnostics Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.2.5 Roche Diagnostics Recent Development
• 13.3 Siemens Healthineer
  • 13.3.1 Siemens Healthineer Company Details
  • 13.3.2 Siemens Healthineer Business Overview
  • 13.3.3 Siemens Healthineer Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.3.4 Siemens Healthineer Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.3.5 Siemens Healthineer Recent Development
• 13.4 ACON Laboratories
  • 13.4.1 ACON Laboratories Company Details
  • 13.4.2 ACON Laboratories Business Overview
  • 13.4.3 ACON Laboratories Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.4.4 ACON Laboratories Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.4.5 ACON Laboratories Recent Development
• 13.5 Abbott
  • 13.5.1 Abbott Company Details
  • 13.5.2 Abbott Business Overview
  • 13.5.3 Abbott Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.5.4 Abbott Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.5.5 Abbott Recent Development
• 13.6 ARKRAY
  • 13.6.1 ARKRAY Company Details
  • 13.6.2 ARKRAY Business Overview
  • 13.6.3 ARKRAY Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.6.4 ARKRAY Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.6.5 ARKRAY Recent Development
• 13.7 Beckman Coulter
  • 13.7.1 Beckman Coulter Company Details
  • 13.7.2 Beckman Coulter Business Overview
  • 13.7.3 Beckman Coulter Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.7.4 Beckman Coulter Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.7.5 Beckman Coulter Recent Development
• 13.8 Becton Dickinson
  • 13.8.1 Becton Dickinson Company Details
  • 13.8.2 Becton Dickinson Business Overview
  • 13.8.3 Becton Dickinson Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.8.4 Becton Dickinson Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.8.5 Becton Dickinson Recent Development
• 13.9 Bio-Rad
  • 13.9.1 Bio-Rad Company Details
  • 13.9.2 Bio-Rad Business Overview
  • 13.9.3 Bio-Rad Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.9.4 Bio-Rad Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.9.5 Bio-Rad Recent Development
• 13.10 Cepheid
  • 13.10.1 Cepheid Company Details
  • 13.10.2 Cepheid Business Overview
  • 13.10.3 Cepheid Hospital-acquired Urinary Tract Infection Testing Introduction
  • 13.10.4 Cepheid Revenue in Hospital-acquired Urinary Tract Infection Testing Business (2015-2020)
  • 13.10.5 Cepheid Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer